Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa
Status:
Completed
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn more about the changes that happen in the brain and the
body when a person is depressed. This study will determine if the level of inflammation in
the body is related to symptoms of depression, how well the person thinks, and how certain
brain regions communicate.
Phase:
Phase 4
Details
Lead Sponsor:
Emory University
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Carbidopa Carbidopa, levodopa drug combination Levodopa